trending Market Intelligence /marketintelligence/en/news-insights/trending/SXZEtkEV0CJx5_TAR7BQbA2 content esgSubNav
In This List

Repros CEO resigns; interim CEO named

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Repros CEO resigns; interim CEO named

Joseph Podolski resigned as president, CEO and board member of Repros Therapeutics Inc. to pursue other interests.

Larry Dillaha, CEO of CavtheRx, has been appointed to serve as interim president and CEO, effective Feb. 2.